IP Library Granted Patent US 7,976,834
Granted Patent B2
US 7,976,834 · App. 11/985,443 · Granted Jul 12, 2011

Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,976,834
App. No.
11/985,443
Granted
Jul 12, 2011
Kind
B2
Abstract

The invention provides a multi-arm block copolymer for use in delivering a variety of bioactive agents. The copolymer of the invention contains a central core from which extend multiple (3 or more) copolymer arms. Each copolymer arm possesses an inner polypeptide segment and an outer hydrophilic polymer segment. Thus, the overall structure of the copolymer comprises an inner core region that includes the central core and the inner polypeptide segment, while the outer core region is hydrophilic in nature. The multi-arm copolymer of the invention is particularly useful for delivery of biologically active agents that can be entrapped within the inner core region.

Claims (22)

1. A method comprising administering to a mammal a pharmaceutical composition, the pharmaceutical comprising:

a unimolecular multi-arm block copolymer having the structure:

A(—O—B-L 1 C) m′ -(L 2 -D-E) n′

wherein:

A is a central core molecule comprising a residue of a polyol selected from the group consisting of glycerol, a reducing sugar, pentaerythritol, hydroxypropyl-β-cyclodextrin and a glycerol oligomer,

O is oxygen,

B is a hydrophilic ethylene glycol oligomer chain having a molecular weight of about 100 Da to about 5,000 Da,

C is a polypeptide segment,

D is a hydrophilic polymer segment selected from the group consisting of poly(alkylene glycols), copolymers of ethylene glycol and propylene glycol, poly(olefinic alcohol), poly(vinylpyrrolidone), poly(hydroxyalkylmethacrylamide), poly(hydroxyalkylmethacrylate), poly(saccharides), poly(α-hydroxy acid), poly(vinyl alcohol), polyphosphazene, polyoxazoline and poly(N-acryloylmorpholine),

E is a capping group or a functional group selected from the group consisting of alkoxy, hydroxyl, active ester, active carbonate, acetal, aldehyde, aldehyde hydrate, alkyl or aryl sulfonate, halide, disulfide, alkenyl, acrylate, methacrylate, acrylamide, active sulfone, amine, hydrazide, thiol, carboxylic acid, isocyanate, isothiocyanate, maleimide, vinylsulfone, dithiopyridine, vinylpyridine, iodoacetamide, epoxide, glyoxal, dione, mesylate, tosylate and tresylate,

L 1 is a linkage between B and C formed from a chemical reaction,

L 2 is a linkage between C and D formed from a chemical reaction,

(m′) is 3 to about 25,

(n′) is 2 to about 25, and (n′)≦(m′), wherein the unimolecular multi-arm block copolymer has a total molecular weight of about 10,000 Da to about 200,000 Da; and,

a biologically active agent entrapped within the inner region of the unimolecular multi-arm block copolymer.

2. The method of claim 1 , wherein the polypeptide segment comprises one or more charged amino acid residues, and wherein the biologically active agent entrapped within the inner core region bears a charge opposite of the charge of the one or more charged amino acid residues.

3. The method of claim 1 , wherein the biologically active agent is covalently attached to an amino acid residue of the polypeptide segment.

4. The method of claim 1 , wherein both the inner core region and the biologically active agent are hydrophobic.

5. The method of claim 1 , wherein the biologically active agent is 5-fluorouracil.

6. The method of claim 1 , wherein the biologically active agent is cis-diaminochloro platinum.

7. The method of claim 1 , wherein the biologically active agent is indomethacin.

8. The method of claim 1 , wherein the biologically active agent is paclitaxel.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 17, 2020
From: TC LENDING, LLC, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 053180/0009 →
RELEASE OF SECURITY INTEREST RECORDED AT REEL 28571, FRAME 0141 Recorded Oct 14, 2015
From: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: NEKTAR THERAPEUTICS
Reel/Frame 036866/0700 →
GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Oct 6, 2015
From: NEKTAR THERAPEUTICS
To: TC LENDING, LLC, AS COLLATERAL AGENT
Reel/Frame 036796/0562 →
GRANT OF SECURITY INTEREST Recorded Jul 17, 2012
From: NEKTAR THERAPEUTICS
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 028571/0141 →
MERGER Recorded Aug 31, 2009
From: NEKTAR THERAPEUTICS AL, CORPORATION
To: NEKTAR THERAPEUTICS
Reel/Frame 023196/0394 →